Pharmacological Modulators of Endoplasmic Reticulum Stress in Metabolic Diseases

Tae Woo Jung, Kyung Mook Choi, Tae Woo Jung, Kyung Mook Choi

Abstract

The endoplasmic reticulum (ER) is the principal organelle responsible for correct protein folding, a step in protein synthesis that is critical for the functional conformation of proteins. ER stress is a primary feature of secretory cells and is involved in the pathogenesis of numerous human diseases, such as certain neurodegenerative and cardiometabolic disorders. The unfolded protein response (UPR) is a defense mechanism to attenuate ER stress and maintain the homeostasis of the organism. Two major degradation systems, including the proteasome and autophagy, are involved in this defense system. If ER stress overwhelms the capacity of the cell's defense mechanisms, apoptotic death may result. This review is focused on the various pharmacological modulators that can protect cells from damage induced by ER stress. The possible mechanisms for cytoprotection are also discussed.

Keywords: AMPK-activated protein kinase; angiotensin II type 1 receptor blockers; endoplasmic reticulum stress; glucagon-like peptide-1; peroxisome proliferator-activated receptors; unfolded protein response.

References

    1. Schroder M., Kaufman R.J. ER stress and the unfolded protein response. Mutat. Res. 2005;569:29–63. doi: 10.1016/j.mrfmmm.2004.06.056.
    1. Varadarajan S., Bampton E.T., Smalley J.L., Tanaka K., Caves R.E., Butterworth M., Wei J., Pellecchia M., Mitcheson J., Gant T.W., et al. A novel cellular stress response characterised by a rapid reorganisation of membranes of the endoplasmic reticulum. Cell Death Differ. 2012;19:1896–1907. doi: 10.1038/cdd.2012.108.
    1. Lipson K.L., Fonseca S.G., Ishigaki S., Nguyen L.X., Foss E., Bortell R., Rossini A.A., Urano F. Regulation of insulin biosynthesis in pancreatic β cells by an endoplasmic reticulum-resident protein kinase IRE1. Cell Metab. 2006;4:245–254. doi: 10.1016/j.cmet.2006.07.007.
    1. Delepine M., Nicolino M., Barrett T., Golamaully M., Lathrop G.M., Julier C. EIF2AK3, encoding translation initiation factor 2-α kinase 3, is mutated in patients with Wolcott-Rallison syndrome. Nat. Genet. 2000;25:406–409.
    1. Ozcan U., Cao Q., Yilmaz E., Lee A.H., Iwakoshi N.N., Ozdelen E., Tuncman G., Gorgun C., Glimcher L.H., Hotamisligil G.S. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science. 2004;306:457–461. doi: 10.1126/science.1103160.
    1. Tersey S.A., Nishiki Y., Templin A.T., Cabrera S.M., Stull N.D., Colvin S.C., Evans-Molina C., Rickus J.L., Maier B., Mirmira R.G. Islet β-cell endoplasmic reticulum stress precedes the onset of type 1 diabetes in the nonobese diabetic mouse model. Diabetes. 2012;61:818–827. doi: 10.2337/db11-1293.
    1. Marhfour I., Lopez X.M., Lefkaditis D., Salmon I., Allagnat F., Richardson S.J., Morgan N.G., Eizirik D.L. Expression of endoplasmic reticulum stress markers in the islets of patients with type 1 diabetes. Diabetologia. 2012;55:2417–2420. doi: 10.1007/s00125-012-2604-3.
    1. Harding H.P., Zeng H., Zhang Y., Jungries R., Chung P., Plesken H., Sabatini D.D., Ron D. Diabetes mellitus and exocrine pancreatic dysfunction in perk−/− mice reveals a role for translational control in secretory cell survival. Mol. Cell. 2001;7:1153–1163. doi: 10.1016/S1097-2765(01)00264-7.
    1. Laybutt D.R., Preston A.M., Akerfeldt M.C., Kench J.G., Busch A.K., Biankin A.V., Biden T.J. Endoplasmic reticulum stress contributes to β cell apoptosis in type 2 diabetes. Diabetologia. 2007;50:752–763. doi: 10.1007/s00125-006-0590-z.
    1. Oyadomari S., Koizumi A., Takeda K., Gotoh T., Akira S., Araki E., Mori M. Targeted disruption of the Chop gene delays endoplasmic reticulum stress-mediated diabetes. J. Clin. Investig. 2002;109:525–532. doi: 10.1172/JCI0214550.
    1. Thameem F., Farook V.S., Bogardus C., Prochazka M. Association of amino acid variants in the activating transcription factor 6 gene (ATF6) on 1q21-q23 with type 2 diabetes in Pima Indians. Diabetes. 2006;55:839–842. doi: 10.2337/diabetes.55.03.06.db05-1002.
    1. Kwon M.J., Chung H.S., Yoon C.S., Ko J.H., Jun H.J., Kim T.K., Lee S.H., Ko K.S., Rhee B.D., Kim M.K., et al. The Effects of glyburide on apoptosis and endoplasmic reticulum stress in INS-1 cells in a glucolipotoxic condition. Diabetes Metab. J. 2011;35:480–488. doi: 10.4093/dmj.2011.35.5.480.
    1. Minamino T., Komuro I., Kitakaze M. Endoplasmic reticulum stress as a therapeutic target in cardiovascular disease. Circ. Res. 2010;107:1071–1082. doi: 10.1161/CIRCRESAHA.110.227819.
    1. Cnop M., Ladriere L., Hekerman P., Ortis F., Cardozo A.K., Dogusan Z., Flamez D., Boyce M., Yuan J., Eizirik D.L. Selective inhibition of eukaryotic translation initiation factor 2α dephosphorylation potentiates fatty acid-induced endoplasmic reticulum stress and causes pancreatic β-cell dysfunction and apoptosis. J. Biol. Chem. 2007;282:3989–3997. doi: 10.1074/jbc.M607627200.
    1. Zhou J., Lhotak S., Hilditch B.A., Austin R.C. Activation of the unfolded protein response occurs at all stages of atherosclerotic lesion development in apolipoprotein E-deficient mice. Circulation. 2005;111:1814–1821. doi: 10.1161/01.CIR.0000160864.31351.C1.
    1. Seimon T.A., Nadolski M.J., Liao X., Magallon J., Nguyen M., Feric N.T., Koschinsky M.L., Harkewicz R., Witztum J.L., Tsimikas S., et al. Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress. Cell Metab. 2010;12:467–482. doi: 10.1016/j.cmet.2010.09.010.
    1. Du K., Herzig S., Kulkarni R.N., Montminy M. TRB3: A tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science. 2003;300:1574–1577. doi: 10.1126/science.1079817.
    1. Passos E., Ascensao A., Martins M.J., Magalhaes J. Endoplasmic reticulum stress response in non-alcoholic steatohepatitis: The possible role of physical exercise. Metabolism. 2015;64:780–792. doi: 10.1016/j.metabol.2015.02.003.
    1. Puri P., Mirshahi F., Cheung O., Natarajan R., Maher J.W., Kellum J.M., Sanyal A.J. Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease. Gastroenterology. 2008;134:568–576. doi: 10.1053/j.gastro.2007.10.039.
    1. Zhang X.Q., Xu C.F., Yu C.H., Chen W.X., Li Y.M. Role of endoplasmic reticulum stress in the pathogenesis of nonalcoholic fatty liver disease. World J. Gastroenterol. 2014;20:1768–1776. doi: 10.3748/wjg.v20.i7.1768.
    1. Oyadomari S., Harding H.P., Zhang Y., Oyadomari M., Ron D. Dephosphorylation of translation initiation factor 2α enhances glucose tolerance and attenuates hepatosteatosis in mice. Cell Metab. 2008;7:520–532. doi: 10.1016/j.cmet.2008.04.011.
    1. Zhang K., Wang S., Malhotra J., Hassler J.R., Back S.H., Wang G., Chang L., Xu W., Miao H., Leonardi R., et al. The unfolded protein response transducer IRE1α prevents ER stress-induced hepatic steatosis. EMBO J. 2011;30:1357–1375. doi: 10.1038/emboj.2011.52.
    1. Usui M., Yamaguchi S., Tanji Y., Tominaga R., Ishigaki Y., Fukumoto M., Katagiri H., Mori K., Oka Y., Ishihara H. Atf6α-null mice are glucose intolerant due to pancreatic β-cell failure on a high-fat diet but partially resistant to diet-induced insulin resistance. Metabolism. 2012;61:1118–1128. doi: 10.1016/j.metabol.2012.01.004.
    1. Shibutani S.T., Yoshimori T. A current perspective of autophagosome biogenesis. Cell Res. 2014;24:58–68. doi: 10.1038/cr.2013.159.
    1. Kouroku Y., Fujita E., Tanida I., Ueno T., Isoai A., Kumagai H., Ogawa S., Kaufman R.J., Kominami E., Momoi T. ER stress (PERK/eIF2α phosphorylation) mediates the polyglutamine-induced LC3 conversion, an essential step for autophagy formation. Cell Death Differ. 2007;14:230–239. doi: 10.1038/sj.cdd.4401984.
    1. Qin L., Wang Z., Tao L., Wang Y. ER stress negatively regulates AKT/TSC/mTOR pathway to enhance autophagy. Autophagy. 2010;6:239–247. doi: 10.4161/auto.6.2.11062.
    1. Yorimitsu T., Klionsky D.J. Endoplasmic reticulum stress: A new pathway to induce autophagy. Autophagy. 2007;3:160–162. doi: 10.4161/auto.3653.
    1. Gonzalez-Rodriguez A., Mayoral R., Agra N., Valdecantos M.P., Pardo V., Miquilena-Colina M.E., Vargas-Castrillon J., Lo Iacono O., Corazzari M., Fimia G.M., et al. Impaired autophagic flux is associated with increased endoplasmic reticulum stress during the development of NAFLD. Cell Death Dis. 2014;5:e1179. doi: 10.1038/cddis.2014.162.
    1. Zhu J., Hua X., Li D., Zhang J., Xia Q. Rapamycin attenuates mouse liver ischemia and reperfusion injury by inhibiting endoplasmic reticulum stress. Transplant. Proc. 2015;47:1646–1652. doi: 10.1016/j.transproceed.2015.05.013.
    1. Wang H., Sun R.Q., Zeng X.Y., Zhou X., Li S., Jo E., Molero J.C., Ye J.M. Restoration of autophagy alleviates hepatic ER stress and impaired insulin signalling transduction in high fructose-fed male mice. Endocrinology. 2015;156:169–181. doi: 10.1210/en.2014-1454.
    1. Yin J., Gu L., Wang Y., Fan N., Ma Y., Peng Y. Rapamycin improves palmitate-induced ER stress/NF κB pathways associated with stimulating autophagy in adipocytes. Mediat. Inflamm. 2015;2015:272313.
    1. Bachar-Wikstrom E., Wikstrom J.D., Kaiser N., Cerasi E., Leibowitz G. Improvement of ER stress-induced diabetes by stimulating autophagy. Autophagy. 2013;9:626–628. doi: 10.4161/auto.23642.
    1. Kato H., Nakajima S., Saito Y., Takahashi S., Katoh R., Kitamura M. mTORC1 serves ER stress-triggered apoptosis via selective activation of the IRE1-JNK pathway. Cell Death Differ. 2012;19:310–320. doi: 10.1038/cdd.2011.98.
    1. Dong G., Liu Y., Zhang L., Huang S., Ding H.F., Dong Z. mTOR contributes to ER stress and associated apoptosis in renal tubular cells. Am. J. Physiol. Ren. Physiol. 2015;308:F267–F274. doi: 10.1152/ajprenal.00629.2014.
    1. Hwang S.L., Li X., Lee J.Y., Chang H.W. Improved insulin sensitivity by rapamycin is associated with reduction of mTOR and S6K1 activities in L6 myotubes. Biochem. Biophys. Res. Commun. 2012;418:402–407. doi: 10.1016/j.bbrc.2012.01.038.
    1. Engin F., Hotamisligil G.S. Restoring endoplasmic reticulum function by chemical chaperones: An emerging therapeutic approach for metabolic diseases. Diabetes Obes. Metab. 2010;12:108–115. doi: 10.1111/j.1463-1326.2010.01282.x.
    1. Welch W.J., Brown C.R. Influence of molecular and chemical chaperones on protein folding. Cell Stress Chaperones. 1996;1:109–115. doi: 10.1379/1466-1268(1996)001<0109:IOMACC>;2.
    1. Basseri S., Lhotak S., Sharma A.M., Austin R.C. The chemical chaperone 4-phenylbutyrate inhibits adipogenesis by modulating the unfolded protein response. J. Lipid Res. 2009;50:2486–2501. doi: 10.1194/jlr.M900216-JLR200.
    1. Xie Q., Khaoustov V.I., Chung C.C., Sohn J., Krishnan B., Lewis D.E., Yoffe B. Effect of tauroursodeoxycholic acid on endoplasmic reticulum stress-induced caspase-12 activation. Hepatology. 2002;36:592–601. doi: 10.1053/jhep.2002.35441.
    1. Ozcan U., Yilmaz E., Ozcan L., Furuhashi M., Vaillancourt E., Smith R.O., Gorgun C.Z., Hotamisligil G.S. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science. 2006;313:1137–1140. doi: 10.1126/science.1128294.
    1. Cho E.J., Yoon J.H., Kwak M.S., Jang E.S., Lee J.H., Yu S.J., Kim Y.J., Kim C.Y., Lee H.S. Tauroursodeoxycholic acid attenuates progression of steatohepatitis in mice fed a methionine-choline-deficient diet. Dig. Dis. Sci. 2014;59:1461–1474. doi: 10.1007/s10620-014-3217-0.
    1. Steinberg G.R., Kemp B.E. AMPK in health and disease. Physiol. Rev. 2009;89:1025–1078. doi: 10.1152/physrev.00011.2008.
    1. Dong Y., Zhang M., Wang S., Liang B., Zhao Z., Liu C., Wu M., Choi H.C., Lyons T.J., Zou M.H. Activation of AMP-activated protein kinase inhibits oxidized LDL-triggered endoplasmic reticulum stress in vivo. Diabetes. 2010;59:1386–1396. doi: 10.2337/db09-1637.
    1. Terai K., Hiramoto Y., Masaki M., Sugiyama S., Kuroda T., Hori M., Kawase I., Hirota H. AMP-activated protein kinase protects cardiomyocytes against hypoxic injury through attenuation of endoplasmic reticulum stress. Mol. Cell. Biol. 2005;25:9554–9575. doi: 10.1128/MCB.25.21.9554-9575.2005.
    1. Kim D.S., Jeong S.K., Kim H.R., Chae S.W., Chae H.J. Metformin regulates palmitate-induced apoptosis and ER stress response in HepG2 liver cells. Immunopharmacol. Immunotoxicol. 2010;32:251–257. doi: 10.3109/08923970903252220.
    1. Simon-Szabo L., Kokas M., Mandl J., Keri G., Csala M. Metformin attenuates palmitate-induced endoplasmic reticulum stress, serine phosphorylation of IRS-1 and apoptosis in rat insulinoma cells. PLoS ONE. 2014;9:192
    1. Kim H., Moon S.Y., Kim J.S., Baek C.H., Kim M., Min J.Y., Lee S.K. Activation of AMP-activated protein kinase inhibits ER stress and renal fibrosis. Am. J. Physiol. Ren. Physiol. 2015;308:F226–F236. doi: 10.1152/ajprenal.00495.2014.
    1. Cheang W.S., Tian X.Y., Wong W.T., Lau C.W., Lee S.S., Chen Z.Y., Yao X., Wang N., Huang Y. Metformin protects endothelial function in diet-induced obese mice by inhibition of endoplasmic reticulum stress through 5' adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor delta pathway. Arterioscler. Thromb. Vasc Biol. 2014;34:830–836. doi: 10.1161/ATVBAHA.113.301938.
    1. Sen S., Kundu B.K., Wu H.C., Hashmi S.S., Guthrie P., Locke L.W., Roy R.J., Matherne G.P., Berr S.S., Terwelp M., et al. Glucose regulation of load-induced mTOR signaling and ER stress in mammalian heart. J. Am. Heart Assoc. 2013;2:e004796. doi: 10.1161/JAHA.113.004796.
    1. Hotamisligil G.S. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell. 2010;140:900–917. doi: 10.1016/j.cell.2010.02.034.
    1. Alhusaini S., McGee K., Schisano B., Harte A., McTernan P., Kumar S., Tripathi G. Lipopolysaccharide, high glucose and saturated fatty acids induce endoplasmic reticulum stress in cultured primary human adipocytes: Salicylate alleviates this stress. Biochem. Biophys. Res. Commun. 2010;397:472–478. doi: 10.1016/j.bbrc.2010.05.138.
    1. Li J., Wang Y., Wen X., Ma X.N., Chen W., Huang F., Kou J., Qi L.W., Liu B., Liu K. Pharmacological activation of AMPK prevents Drp1-mediated mitochondrial fission and alleviates endoplasmic reticulum stress-associated endothelial dysfunction. J. Mol. Cell. Cardiol. 2015;86:62–74. doi: 10.1016/j.yjmcc.2015.07.010.
    1. Jung T.W., Lee S.Y., Hong H.C., Choi H.Y., Yoo H.J., Baik S.H., Choi K.M. AMPK activator-mediated inhibition of endoplasmic reticulum stress ameliorates carrageenan-induced insulin resistance through the suppression of selenoprotein P in HepG2 hepatocytes. Mol. Cell. Endocrinol. 2014;382:66–73. doi: 10.1016/j.mce.2013.09.013.
    1. Kieffer T.J., Habener J.F. The glucagon-like peptides. Endocr. Rev. 1999;20:876–913. doi: 10.1210/edrv.20.6.0385.
    1. Farilla L., Bulotta A., Hirshberg B., Li Calzi S., Khoury N., Noushmehr H., Bertolotto C., di Mario U., Harlan D.M., Perfetti R. Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets. Endocrinology. 2003;144:5149–5158. doi: 10.1210/en.2003-0323.
    1. Kang M.Y., Oh T.J., Cho Y.M. Glucagon-like peptide-1 increases mitochondrial biogenesis and function in INS-1 Rat Insulinoma Cells. Endocrinol. Metab. (Seoul) 2015;30:216–220. doi: 10.3803/EnM.2015.30.2.216.
    1. Buteau J., Foisy S., Joly E., Prentki M. Glucagon-like peptide 1 induces pancreatic β-cell proliferation via transactivation of the epidermal growth factor receptor. Diabetes. 2003;52:124–132. doi: 10.2337/diabetes.52.1.124.
    1. Hui H., Wright C., Perfetti R. Glucagon-like peptide 1 induces differentiation of islet duodenal homeobox-1-positive pancreatic ductal cells into insulin-secreting cells. Diabetes. 2001;50:785–796. doi: 10.2337/diabetes.50.4.785.
    1. Yusta B., Baggio L.L., Estall J.L., Koehler J.A., Holland D.P., Li H., Pipeleers D., Ling Z., Drucker D.J. GLP-1 receptor activation improves β cell function and survival following induction of endoplasmic reticulum stress. Cell Metab. 2006;4:391–406. doi: 10.1016/j.cmet.2006.10.001.
    1. Cunha D.A., Ladriere L., Ortis F., Igoillo-Esteve M., Gurzov E.N., Lupi R., Marchetti P., Eizirik D.L., Cnop M. Glucagon-like peptide-1 agonists protect pancreatic β-cells from lipotoxic endoplasmic reticulum stress through upregulation of BiP and JunB. Diabetes. 2009;58:2851–2862. doi: 10.2337/db09-0685.
    1. Yamane S., Hamamoto Y., Harashima S., Harada N., Hamasaki A., Toyoda K., Fujita K., Joo E., Seino Y., Inagaki N. GLP-1 receptor agonist attenuates endoplasmic reticulum stress-mediated β-cell damage in Akita mice. J. Diabetes Investig. 2011;2:104–110. doi: 10.1111/j.2040-1124.2010.00075.x.
    1. Oh Y.S., Lee Y.J., Kang Y., Han J., Lim O.K., Jun H.S. Exendin-4 inhibits glucolipotoxic ER stress in pancreatic beta cells via regulation of SREBP1c and C/EBPβ transcription factors. J. Endocrinol. 2013;216:343–352. doi: 10.1530/JOE-12-0311.
    1. Berridge M.J. The endoplasmic reticulum: A multifunctional signaling organelle. Cell Calcium. 2002;32:235–249. doi: 10.1016/S0143416002001823.
    1. Zhang J., Li Y., Jiang S., Yu H., An W. Enhanced endoplasmic reticulum SERCA activity by overexpression of hepatic stimulator substance gene prevents hepatic cells from ER stress-induced apoptosis. Am. J. Physiol. Cell Physiol. 2014;306:C279–C290. doi: 10.1152/ajpcell.00117.2013.
    1. Fu S., Yang L., Li P., Hofmann O., Dicker L., Hide W., Lin X., Watkins S.M., Ivanov A.R., Hotamisligil G.S. Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity. Nature. 2011;473:528–531. doi: 10.1038/nature09968.
    1. Younce C.W., Burmeister M.A., Ayala J.E. Exendin-4 attenuates high glucose-induced cardiomyocyte apoptosis via inhibition of endoplasmic reticulum stress and activation of SERCA2a. Am. J. Physiol. Cell Physiol. 2013;304:C508–C518. doi: 10.1152/ajpcell.00248.2012.
    1. Lee J., Hong S.W., Park S.E., Rhee E.J., Park C.Y., Oh K.W., Park S.W., Lee W.Y. Exendin-4 attenuates endoplasmic reticulum stress through a SIRT1-dependent mechanism. Cell Stress Chaperones. 2014;19:649–656. doi: 10.1007/s12192-013-0490-3.
    1. Sharma S., Mells J.E., Fu P.P., Saxena N.K., Anania F.A. GLP-1 analogs reduce hepatocyte steatosis and improve survival by enhancing the unfolded protein response and promoting macroautophagy. PLoS ONE. 2011;6:192. doi: 10.1371/journal.pone.0025269.
    1. Barnett A. DPP-4 inhibitors and their potential role in the management of type 2 diabetes. Int. J. Clin. Pract. 2006;60:1454–1470. doi: 10.1111/j.1742-1241.2006.01178.x.
    1. Shimizu S., Hosooka T., Matsuda T., Asahara S., Koyanagi-Kimura M., Kanno A., Bartolome A., Etoh H., Fuchita M., Teruyama K., et al. DPP4 inhibitor vildagliptin preserves β-cell mass through amelioration of endoplasmic reticulum stress in C/EBPB transgenic mice. J. Mol. Endocrinol. 2012;49:125–135. doi: 10.1530/JME-12-0039.
    1. Jung Y.A., Choi Y.K., Jung G.S., Seo H.Y., Kim H.S., Jang B.K., Kim J.G., Lee I.K., Kim M.K., Park K.G. Sitagliptin attenuates methionine/choline-deficient diet-induced steatohepatitis. Diabetes Res. Clin. Pract. 2014;105:47–57. doi: 10.1016/j.diabres.2014.04.028.
    1. Hwang H.J., Jung T.W., Ryu J.Y., Hong H.C., Choi H.Y., Seo J.A., Kim S.G., Kim N.H., Choi K.M., Choi D.S., et al. Dipeptidyl petidase-IV inhibitor (gemigliptin) inhibits tunicamycin-induced endoplasmic reticulum stress, apoptosis and inflammation in H9c2 cardiomyocytes. Mol. Cell. Endocrinol. 2014;392:1–7. doi: 10.1016/j.mce.2014.04.017.
    1. Zhang N., Lu Y., Shen X., Bao Y., Cheng J., Chen L., Li B., Zhang Q. Fenofibrate treatment attenuated chronic endoplasmic reticulum stress in the liver of nonalcoholic fatty liver disease mice. Pharmacology. 2015;95:173–180. doi: 10.1159/000380952.
    1. Rahman S.M., Qadri I., Janssen R.C., Friedman J.E. Fenofibrate and PBA prevent fatty acid-induced loss of adiponectin receptor and pAMPK in human hepatoma cells and in hepatitis C virus-induced steatosis. J. Lipid Res. 2009;50:2193–2202. doi: 10.1194/jlr.M800633-JLR200.
    1. Lu Y., Cheng J., Chen L., Li C., Chen G., Gui L., Shen B., Zhang Q. Endoplasmic reticulum stress involved in high-fat diet and palmitic acid-induced vascular damages and fenofibrate intervention. Biochem. Biophys. Res. Commun. 2015;458:1–7. doi: 10.1016/j.bbrc.2014.12.123.
    1. Kono T., Ahn G., Moss D.R., Gann L., Zarain-Herzberg A., Nishiki Y., Fueger P.T., Ogihara T., Evans-Molina C. PPAR-γ activation restores pancreatic islet SERCA2 levels and prevents β-cell dysfunction under conditions of hyperglycemic and cytokine stress. Mol. Endocrinol. 2012;26:257–271. doi: 10.1210/me.2011-1181.
    1. Yoshiuchi K., Kaneto H., Matsuoka T.A., Kasami R., Kohno K., Iwawaki T., Nakatani Y., Yamasaki Y., Shimomura I., Matsuhisa M. Pioglitazone reduces ER stress in the liver: Direct monitoring of in vivo ER stress using ER stress-activated indicator transgenic mice. Endocr. J. 2009;56:1103–1111. doi: 10.1507/endocrj.K09E-140.
    1. Peter A., Weigert C., Staiger H., Machicao F., Schick F., Machann J., Stefan N., Thamer C., Haring H.U., Schleicher E. Individual stearoyl-coa desaturase 1 expression modulates endoplasmic reticulum stress and inflammation in human myotubes and is associated with skeletal muscle lipid storage and insulin sensitivity in vivo. Diabetes. 2009;58:1757–1765. doi: 10.2337/db09-0188.
    1. Thorn K., Hovsepyan M., Bergsten P. Reduced levels of SCD1 accentuate palmitate-induced stress in insulin-producing β-cells. Lipids Health Dis. 2010;9:108. doi: 10.1186/1476-511X-9-108.
    1. Ikeda J., Ichiki T., Takahara Y., Kojima H., Sankoda C., Kitamoto S., Tokunou T., Sunagawa K. PPARγ agonists attenuate palmitate-induced ER stress through up-regulation of SCD-1 in macrophages. PLoS ONE. 2015;10:192. doi: 10.1371/journal.pone.0128546.
    1. Salvado L., Barroso E., Gomez-Foix A.M., Palomer X., Michalik L., Wahli W., Vazquez-Carrera M. PPARβ/δ prevents endoplasmic reticulum stress-associated inflammation and insulin resistance in skeletal muscle cells through an AMPK-dependent mechanism. Diabetologia. 2014;57:2126–2135. doi: 10.1007/s00125-014-3331-8.
    1. Alvarez-Guardia D., Palomer X., Coll T., Serrano L., Rodriguez-Calvo R., Davidson M.M., Merlos M., El Kochairi I., Michalik L., Wahli W., et al. PPARβ/δ activation blocks lipid-induced inflammatory pathways in mouse heart and human cardiac cells. Biochim. Biophys. Acta. 2011;1811:59–67. doi: 10.1016/j.bbalip.2010.11.002.
    1. Palomer X., Capdevila-Busquets E., Botteri G., Salvado L., Barroso E., Davidson M.M., Michalik L., Wahli W., Vazquez-Carrera M. PPARβ/δ attenuates palmitate-induced endoplasmic reticulum stress and induces autophagic markers in human cardiac cells. Int. J. Cardiol. 2014;174:110–118. doi: 10.1016/j.ijcard.2014.03.176.
    1. Wu T., Dong Z., Geng J., Sun Y., Liu G., Kang W., Zhang Y., Ge Z. Valsartan protects against ER stress-induced myocardial apoptosis via CHOP/Puma signaling pathway in streptozotocin-induced diabetic rats. Eur. J. Pharm. Sci. 2011;42:496–502. doi: 10.1016/j.ejps.2011.02.005.
    1. Peng P.A., Wang L., Ma Q., Xin Y., Zhang O., Han H.Y., Liu X.L., Ji Q.W., Zhou Y.J., Zhao Y.X. Valsartan protects HK-2 cells from contrast media-induced apoptosis by inhibiting endoplasmic reticulum stress. Cell Biol. Int. 2015;39:1408–1417. doi: 10.1002/cbin.10521.
    1. Madec A.M., Cassel R., Dubois S., Ducreux S., Vial G., Chauvin M.A., Mesnier A., Chikh K., Bosco D., Rieusset J., et al. Losartan, an angiotensin II type 1 receptor blocker, protects human islets from glucotoxicity through the phospholipase C pathway. FASEB. J. 2013;27:5122–5130. doi: 10.1096/fj.13-234104.
    1. Sukumaran V., Watanabe K., Veeraveedu P.T., Gurusamy N., Ma M., Thandavarayan R.A., Lakshmanan A.P., Yamaguchi K., Suzuki K., Kodama M. Olmesartan, an AT1 antagonist, attenuates oxidative stress, endoplasmic reticulum stress and cardiac inflammatory mediators in rats with heart failure induced by experimental autoimmune myocarditis. Int. J. Biol. Sci. 2011;7:154–167. doi: 10.7150/ijbs.7.154.
    1. Guan H.S., Shangguan H.J., Shang Z., Yang L., Meng X.M., Qiao S.B. Endoplasmic reticulum stress caused by left ventricular hypertrophy in rats: Effects of telmisartan. Am. J. Med. Sci. 2011;342:318–323. doi: 10.1097/MAJ.0b013e3182112baf.
    1. Chan J.Y., Cooney G.J., Biden T.J., Laybutt D.R. Differential regulation of adaptive and apoptotic unfolded protein response signalling by cytokine-induced nitric oxide production in mouse pancreatic beta cells. Diabetologia. 2011;54:1766–1776. doi: 10.1007/s00125-011-2139-z.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe